Replimune Group Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Replimune Group Inc
TickerREPL
CIK #0001737953
CUSIP76029N106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address18 Commerce Way, Woburn, MA 01801
Source [EDGAR]
CIK Filing 2011 - 2026
[0001737953] 10-K
[0001737953] 10-Q
[0001737953] 3
[0001737953] 4
[0001737953] 8-K
[0001737953] SC 13D
[0001737953] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Ridgeback Capital Investments LP Replimune Group Inc [2026-05-21] 0.0
Suvretta Capital Management LLC Replimune Group Inc [2026-05-12] 0.0
RTW Investments LP Replimune Group Inc [2025-11-14] 0.0
Point72 Asset Management LP Replimune Group Inc [2025-07-31] 0.0
Baker Bros Advisors LP Replimune Group Inc [2025-03-07] 0.0
Morgan Stanley Replimune Group Inc [2024-02-09] 7.4
State Street Corp Replimune Group Inc [2024-01-25] 8.65
Baker Bros Advisors LP Replimune Group Inc [2023-02-14] 9.99
BlackRock Inc Replimune Group Inc [2023-02-03] 5.5
Price T Rowe Associates Inc /MD/ Replimune Group Inc [2021-02-16] 5.7
FMR LLC Replimune Group Inc [2021-02-08] 0.0
Atlas Venture Fund X LP Replimune Group Inc [2019-11-25] 10.8
Biotechnology Value Fund L P Replimune Group Inc [2019-03-26] 2.4
Coffin Robert Replimune Group Inc [2019-02-14] 8.0
Forbion Capital Fund III Cooperatief UA Replimune Group Inc [2019-02-14] 15.75
Atlas Venture Fund X LP Replimune Group Inc [2019-02-13] 14.1
Omega Fund IV LP Replimune Group Inc [2019-02-13] 16.2
Foresite Capital Fund III LP Replimune Group Inc [2019-01-23] 2.5
Bain Capital Life Sciences Fund LP Replimune Group Inc [2018-08-01] 8.2
Redmile Group LLC Replimune Group Inc [2018-07-25] 7.1
Form 3/4/5 Filer 2011 - 2026
Sarchi Christopher
Replimune Group Inc
Hill Emily Luisa
Patel Sushil
Schwendenman Andrew
Astley-Sparke Philip
Xynos Konstantinos
Dhingra Kapil
Pucci Paolo
Slattery Joseph P
Peeples-Dyer Veleka
Weinand Dieter
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Oliger Christy J
Balachandran Madhavan
Goller Michael
Love Colin
Coffin Robert
Levitsky Hyam
Esposito Pamela
Lewis Tanya
Franchi Jean M
Slootweg Hugo Alexander
Rhodes Jason P
Stampacchia Otello
Omega Fund IV LP
Omega Fund IV GP LP
Omega Fund IV GP Manager Ltd
Pirzkall Andrea
Paster Anne-Mari
Atlas Venture Fund X LP
Gorgol Stephen A
Kaufman Howard
Atlas Venture Opportunity Fund I LP
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I LP
Lim Richard J
Bain Capital Life Sciences Fund LP
Schwartz Jeffrey Lawrence
BCIP Life Sciences Associates LP
Bain Capital Life Sciences Partners LP
Koppel Adam
Bain Capital Life Sciences Investors LLC
Atlas Venture Associates X LLC
Atlas Venture Associates X LP
Forbion Capital Fund III Cooperatief UA
Redmile Group LLC
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Astley-Sparke Philip
Common Stock
2026-02-18 Gift 25,000 $0.00
Schwendenman Andrew
Common Stock
2025-12-19 Grant 10,000 $0.00
Hill Emily Luisa
Common Stock
2025-12-19 Grant 60,000 $0.00
Sarchi Christopher
Common Stock
2025-12-19 Grant 35,000 $0.00
Patel Sushil
Common Stock
2025-12-19 Grant 200,000 $0.00
Xynos Konstantinos
Common Stock
2025-12-19 Grant 60,000 $0.00
Dhingra Kapil
Stock Option (right to buy) · derivative
2025-12-09 Option exercise 3,169 $0.00
Dhingra Kapil
Common Stock
2025-12-09 Option exercise 3,169 $1.75 5,546
Dhingra Kapil
Common Stock
2025-12-09 Sell 3,169 $10.40 32,958
Patel Sushil
Common Stock
2025-12-02 Sell 10,000 $11.13 111,300
Sarchi Christopher
Common Stock
2025-11-17 Sell 5,208 $9.10 47,393
Xynos Konstantinos
Common Stock
2025-11-17 Sell 7,248 $9.10 65,957
Hill Emily Luisa
Common Stock
2025-08-15 Sell 9,154 $5.37 49,157
Astley-Sparke Philip
Common Stock
2025-05-20 Sell 32,279 $8.06 260,169
Sarchi Christopher
Common Stock
2025-05-20 Sell 3,749 $8.05 30,179
Hill Emily Luisa
Common Stock
2025-05-20 Sell 2,535 $8.05 20,407
Schwendenman Andrew
Common Stock
2025-05-20 Sell 3,287 $8.05 26,460
Patel Sushil
Common Stock
2025-05-20 Sell 25,105 $8.06 202,346
Xynos Konstantinos
Common Stock
2025-05-20 Sell 7,952 $8.06 64,093
Balachandran Madhavan
Stock Option (right to buy) · derivative
2025-04-01 Grant 32,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 188 80,211,137
2025-12-31 171 76,632,765
2025-09-30 174 85,599,933
2025-06-30 177 75,014,588
2025-03-31 169 71,620,166
2024-12-31 158 67,023,429
2024-09-30 145 60,250,109
2024-06-30 150 61,894,353
2024-03-31 152 66,300,510
2023-12-31 141 65,310,158
2023-09-30 134 50,665,487
2023-06-30 144 48,865,151
Form 13F Holdings
Firm Period DFND Voting Shares
TEMA ETFS LLC [2026-06-30] SOLE 75,572 75,572
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 1,924 47,414
Ballentine Partners LLC [2026-06-30] OTR 0 22,046
Breakwater Capital Group [2026-06-30] SOLE 0 19,900
Merit Financial Group LLC [2026-06-30] OTR 0 15,604
Farther Finance Advisors LLC [2026-06-30] SOLE 0 5,694
Merit Financial Group LLC [2026-06-30] SOLE 0 4,460
Gamma Investing LLC [2026-06-30] DFND 1,908 1,908
Beaird Harris Wealth Management LLC [2026-06-30] SOLE 0 680
Versant Capital Management Inc [2026-06-30] SOLE 540 540
Corecap Advisors LLC [2026-06-30] SOLE 0 238
Aventura Private Wealth LLC [2026-06-30] SOLE 200 200
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 177 177
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 151
IFP Advisors LLC [2026-06-30] SOLE 96 96
Fortitude Family Office LLC [2026-06-30] SOLE 56 56
Hughes Financial Services LLC [2026-06-30] SOLE 14 14
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com